Benlysta 200 MG/ML autoinjectml
Ended Awarded Last action
- Contract number
- SPE2DR26F4E6B
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,433
Award facts
- Contract value 100% obligated
- $17,433.35 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded January 7, 2026, by the Defense Logistics Agency to AmerisourceBergen Drug Corp, provides Benlysta 200 mg/mL auto-injector pharmaceutical supplies with a ceiling value of $17,433.35 and an ultimate completion date of January 29, 2026. The award utilizes a firm fixed-price structure with no set-aside designation, reflecting open competition. The contract is performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for delivering comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally.
AmerisourceBergen functions as a critical pharmaceutical distributor for federal military and veteran healthcare systems, consistently delivering brand-name and generic medications, vaccines, and specialized medical commodities across multiple therapeutic domains. The DLA Medical Supply Chain leverages AmerisourceBergen's extensive distribution capabilities to fulfill essential pharmaceutical requirements for military treatment facilities and Defense Health Agency programs worldwide. The firm fixed-price delivery order structure and competitive award history demonstrate the contractor's established capability to meet federal procurement standards for specialized pharmaceutical products supporting defense healthcare operations.
Quick answers
Who was awarded contract SPE2DR26F4E6B?
SPE2DR26F4E6B was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F4E6B worth?
The government has obligated $17,433 on SPE2DR26F4E6B.
Is contract SPE2DR26F4E6B an order under another contract?
Yes. SPE2DR26F4E6B is a delivery order under SPE2DR25D3012, an indefinite delivery contract.
Was contract SPE2DR26F4E6B competed?
The extent of competition for SPE2DR26F4E6B was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award